1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011.
|
2
|
Kaplan AL, Litwin MS and Chamie K: The
future of bladder cancer care in the USA. Nat Rev Urol. 11:59–62.
2014.
|
3
|
Botteman MF, Pashos CL, Redaelli A, Laskin
B and Hauser R: The health economics of bladder cancer: a
comprehensive review of the published literature.
Pharmacoeconomics. 21:1315–1330. 2003.
|
4
|
Christoforidou EP, Riza E, Kales SN, et
al: Bladder cancer and arsenic through drinking water: a systematic
review of epidemiologic evidence. J Environ Sci Health A Tox Hazard
Subst Environ Eng. 48:1764–1775. 2013.
|
5
|
Rodriguez Faba O, Gaya JM, López JM, et
al: Current management of non-muscle-invasive bladder cancer.
Minerva Med. 104:273–286. 2013.
|
6
|
Cheung G, Sahai A, Billia M, Dasgupta P
and Khan MS: Recent advances in the diagnosis and treatment of
bladder cancer. BMC Med. 11:132013.
|
7
|
Clifton MM and Tollefson MK: Anatomic
basis of radical cystectomy and orthotopic urinary diversion in
female patients. Clin Anat. 26:105–109. 2013.
|
8
|
Kübler H and Gschwend JE: Ileal neobladder
in women with bladder cancer: cancer control and functional
aspects. Curr Opin Urol. 21:478–482. 2011.
|
9
|
Aboumarzouk OM, Drewa T, Olejniczak P and
Chlosta PL: Laparoscopic radical cystectomy: a 5-year review of a
single institute’s operative data and complications and a
systematic review of the literature. Int Braz J Urol. 38:330–340.
2012.
|
10
|
Huang J, Lin T, Xu K, et al: Laparoscopic
radical cystectomy with orthotopic ileal neobladder: a report of 85
cases. J Endourol. 22:939–946. 2008.
|
11
|
Challacombe BJ, Bochner BH, Dasgupta P, et
al: The role of laparoscopic and robotic cystectomy in the
management of muscle-invasive bladder cancer with special emphasis
on cancer control and complications. Eur Urol. 60:767–775.
2011.
|
12
|
Theofrastous JP, Whiteside J and Paraiso
MF: The utility of urodynamic testing. J Am Assoc Gynecol Laparosc.
10:548–552. 2003.
|
13
|
Mossanen M and Gore JL: The burden of
bladder cancer care: direct and indirect costs. Curr Opin Urol. May
30–2014.(Epub ahead of print).
|
14
|
Mueller J, Schrader AJ, Schrader M,
Schnoeller T and Jentzmik F: Management of muscle-invasive bladder
cancer. Minerva Urol Nefrol. 65:235–248. 2013.
|
15
|
Azzouni F: Current status of minimally
invasive radical cystectomy: an outcome-based comparison. Exp Rev
Anticancer Ther. 13:681–695. 2013.
|
16
|
Nix J, Smith A, Kurpad R, Nielsen ME,
Wallen EM and Pruthi RS: Prospective randomized controlled trial of
robotic versus open radical cystectomy for bladder cancer:
perioperative and pathologic results. Eur Urol. 57:196–201.
2010.
|
17
|
Izquierdo L, Bolton DM and Lawrentschuk N:
Radical cystectomy and orthotopic bladder substitution: surgical
tricks and management of complications. Minerva Urol Nefrol.
65:225–234. 2013.
|
18
|
Berger A and Aron M: Laparoscopic radical
cystectomy: long-term outcomes. Curr Opin Urol. 18:167–172.
2008.
|
19
|
Roghmann F, Becker A, Trinh QD, et al:
Updated assessment of neobladder utilization and morbidity
according to urinary diversion after radical cystectomy: A
contemporary US-population-based cohort. Can Urol Assoc J.
7:E552–E560. 2013.
|
20
|
Herdiman O, Ong K, Johnson L and
Lawrentschuk N: Orthotopic bladder substitution (Neobladder): part
II: postoperative complications, management, and long-term
follow-up. J Wound Ostomy Continence Nurs. 40:171–180. 2013.
|
21
|
Hart S, Skinner EC, Meyerowitz BE, Boyd S,
Lieskovsky G and Skinner DG: Quality of life after radical
cystectomy for bladder cancer in patients with an ileal conduit,
cutaneous or urethral kock pouch. J Urol. 162:77–81. 1999.
|
22
|
Guan Z, Li J and Yang R: Impacts of
different grafts for bladder reconstruction on postoperative
recovery of the patients. Nan Fang Yi Ke Da Xue Xue Bao.
33:1250–1252. 2013.(In Chinese).
|
23
|
Marim G, Bal K, Balci U, Girgin C and
Dinçel C: Long-term urodynamic and functional analysis of
orthotopic ‘W’ ileal neobladder following radical cystectomy. Int
Urol Nephrol. 40:629–636. 2008.
|
24
|
Chapple C: Overview on the lower urinary
tract. Handb Exp Pharmacol. 202:1–14. 2011.
|
25
|
Chen Z, Lu G, Li X, et al: Better
compliance contributes to better nocturnal continence with
orthotopic ileal neobladder than ileocolonic neobladder after
radical cystectomy for bladder cancer. Urology. 73:838–844.
2009.
|
26
|
Schrier BP, Laguna MP, van der Pal F,
Isorna S and Witjes JA: Comparison of orthotopic sigmoid and ileal
neobladders: continence and urodynamic parameters. Europ Urol.
47:679–685. 2005.
|